{module_contentholder,688483 ice:editable="content"}

Investors

Best-in-Class Treatment for DDD

Notogen presents a unique opportunity to invest in the expansive spine, orthopedic and sports medicine therapeutic technology space. A profound void exists in the continuum of care related to non-surgical intervention for back pain. NTG-101 is positioned to address this void with a simple, cost-effective solution. Notogen has secured investment to achieve near-term goals and is currently seeking additional investment to support future milestones.